Reuters logo
8 months ago
BRIEF-Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca
December 23, 2016 / 8:24 AM / 8 months ago

BRIEF-Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca

Dec 23 (Reuters) - Pfizer Inc :

* Says completed acquisition of development rights to Astrazeneca's late-stage anti-infective business, primarily outside united states

* Pfizer completes acquisition of small molecule anti-infective business from Astrazeneca Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below